An integrative pharmacovigilance, network toxicology and molecular docking study on drug-induced cheilitis
Frontiers in Pharmacology · 20.03.2026 · 17
DOI: 10.3389/fphar.2026.1757807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.03.2026. Verfasst von Xuefeng Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, The Affiliated Hospital of Chengde Medical University, Chengde, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Drug-induced cheilitis represents an inadequately comprehended adverse reaction, with limited understanding of its underlying mechanisms. This study employs an integrative approach, combining pharmacovigilance, network toxicology, and molecular docking methodologies, to systematically examine the phenomenon of drug-associated cheilitis.
Methods
We conducted an analysis of 5,007 cheilitis reports obtained from the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (FDA Adverse Event Reporting System, 2004–2025) by employing disproportionality analysis and multivariate logistic regression techniques. Utilizing network toxicology, we constructed protein–protein interaction networks and identified enriched pathways. Furthermore, molecular docking and 500 ns molecular dynamics simulations were employed to validate the binding interactions between high-risk pharmacological agents and core molecular targets.
Results
Thirty-eight pharmaceuticals demonstrated significant associations with cheilitis, with isotretinoin being the most frequently reported (ROR = 42.61) and crisaborole exhibiting the most pronounced signal (ROR = 550.48). Female sex emerged as an independent risk factor (OR = 0.771), whereas age and weight appeared to offer modest protective effects. Network analysis identified Interleukin 6 (IL6), tumor necrosis factor (TNF), AKT Serine/Threonine Kinase 1 (AKT1), Vascular Endothelial Growth Factor A (VEGFA) and Signal Transducer and Activator of Transcription 3 (STAT3) as central targets, with notable enrichment in the IL-17, TNF, and PI3K-Akt signaling pathways. Molecular docking studies indicated strong binding affinities (ranging from −8.1 to −6.2 kcal/mol), particularly for the afatinib-EGFR and capecitabine-IL-6 interactions. Molecular dynamics simulations confirmed the stability of these complexes, with MM/PBSA analysis highlighting key stabilizing residues. ADMET profiling predicted a high risk of drug-induced liver injury for four compounds, while lamotrigine demonstrated a favorable safety profile.
Conclusion
This integrative framework connects population-level indicators with mechanistic forecasts, providing a translational model for comprehending, predicting, and managing drug-induced cheilitis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Stomatology, The Affiliated Hospital of Chengde Medical University, Chengde, China.
- Department of Thyroid Surgery, The Affiliated Hospital of Chengde Medical University, Chengde, China.
- Department of Pharmacy, The Affiliated Hospital of Chengde Medical University, Chengde, China.
Zitieren
APA
Wang, X., Han, S., Huang, Y., Zhang, L., Li, X., Yang, L., & Zhang, Y. (2026). An integrative pharmacovigilance, network toxicology and molecular docking study on drug-induced cheilitis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1757807
Vancouver
Wang X, Han S, Huang Y, Zhang L, Li X, Yang L, et al. An integrative pharmacovigilance, network toxicology and molecular docking study on drug-induced cheilitis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1757807
BibTeX
@article{Wang2026,
author = {Wang, Xuefeng and Han, Shangzhi and Huang, Yingxue and Zhang, Lei and Li, Xue and Yang, Liqin and Zhang, Yanbo},
title = {An integrative pharmacovigilance, network toxicology and molecular docking study on drug-induced cheilitis},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1757807}
}
EUVIMED